BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18446808)

  • 1. Monodisperse gelatin microspheres as a drug delivery vehicle: release profile and effect of crosslinking density.
    Choy YB; Cheng F; Choi H; Kim KK
    Macromol Biosci; 2008 Aug; 8(8):758-65. PubMed ID: 18446808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of small-molecule release from crosslinked hydrogel microspheres: effect of crosslinking and enzymatic degradation of hydrogel matrix.
    Cheng F; Choy YB; Choi H; Kim KK
    Int J Pharm; 2011 Jan; 403(1-2):90-5. PubMed ID: 20971173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.
    Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M
    Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis and properties evaluation of gelatin microspheres crosslinked with glutaraldehyde and 3-glycidoxypropyltrimethoxysilane as drug delivery systems for the antibiotic vancomycin.
    Nouri-Felekori M; Khakbiz M; Nezafati N; Mohammadi J; Eslaminejad MB
    Int J Pharm; 2019 Feb; 557():208-220. PubMed ID: 30597262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
    Dinarvand R; Mahmoodi S; Farboud E; Salehi M; Atyabi F
    Acta Pharm; 2005 Mar; 55(1):57-67. PubMed ID: 15907224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and in vitro evaluation of gelatin microspheres containing an antitumour tetra-amidine.
    Nastruzzi C; Pastesini C; Cortesi R; Esposito E; Gambari R; Menegatti E
    J Microencapsul; 1994; 11(3):249-60. PubMed ID: 8064549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung-targeted delivery system of curcumin loaded gelatin microspheres.
    Cao F; Ding B; Sun M; Guo C; Zhang L; Zhai G
    Drug Deliv; 2011 Nov; 18(8):545-54. PubMed ID: 21812751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release properties of chemical and enzymatic crosslinked gelatin-gum Arabic microparticles containing a fluorescent probe plus vetiver essential oil.
    Prata AS; Zanin MH; Ré MI; Grosso CR
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):171-8. PubMed ID: 18835139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of gelatin microspheres loaded with diclofenac sodium for intra-articular administration.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    J Drug Target; 2011 Feb; 19(2):96-103. PubMed ID: 20380621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY; Gu YH; Su ZG; Ma GH
    Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The micro patterning of glutaraldehyde (GA)-crosslinked gelatin and its application to cell-culture.
    Yang LJ; Ou YC
    Lab Chip; 2005 Sep; 5(9):979-84. PubMed ID: 16100583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desferrioxamine release from gelatin-based systems.
    Ulubayram K; Kiziltay A; Yilmaz E; Hasirci N
    Biotechnol Appl Biochem; 2005 Dec; 42(Pt 3):237-45. PubMed ID: 15984929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres.
    Kasper FK; Kushibiki T; Kimura Y; Mikos AG; Tabata Y
    J Control Release; 2005 Oct; 107(3):547-61. PubMed ID: 16139915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process.
    Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K
    Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
    Gu YH; Wang LY; Tan TW; Ma GH
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells.
    Madan J; Pandey RS; Jain UK; Katare OP; Aneja R; Katyal A
    Colloids Surf B Biointerfaces; 2013 Jul; 107():235-44. PubMed ID: 23502046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide loaded albumin microspheres II. Release characteristics.
    Vural I; Kaş HS; Hincal AA; Cavé G
    J Microencapsul; 1990; 7(4):511-6. PubMed ID: 2125078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and characterization of curcumin loaded gelatin microspheres for lung targeting].
    Cao FL; Xi YW; Tang L; Yu AH; Zhai GX
    Zhong Yao Cai; 2009 Mar; 32(3):423-6. PubMed ID: 19565724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
    Muvaffak A; Gurhan I; Gunduz U; Hasirci N
    J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uniform chitosan microspheres for potential application to colon-specific drug delivery.
    Choy YB; Cheng F; Choi H; Kim KK
    Macromol Biosci; 2008 Dec; 8(12):1173-81. PubMed ID: 18702170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.